Mandibular Advancement Devices Market

Mandibular Advancement Devices Market Size:

The global mandibular advancement devices market size reached US$ 701.3 Million in ​2023​. Looking forward, IMARC Group expects the market to reach US$ 1,574.1 Million by ​2032​, exhibiting a growth rate (CAGR) of 8.5% during 2024-2032. The market is experiencing significant growth mainly due to rising awareness of sleep apnea and the increased demand for non-invasive treatments. Significant technological advancements, increasing patient preference for alternatives to CPAP, and favorable regulatory policies are also contributing positively to the market growth.

Mandibular Advancement Devices Market Analysis:

• Major Market Drivers: Key market drivers include the rising prevalence of obstructive sleep apnea (OSA), which, in turn, is contributing significantly to the growing demand for non-invasive treatments. Technological advancements, such as 3D printing and customizable designs are enhancing device comfort and effectiveness, thereby driving the market growth. In line with this, increase in patient preference for alternatives to CPAP therapy, favorable regulatory support and expanded insurance coverage are boosting adoption. The growing emphasis on home-based treatments and telemedicine solutions further accelerates the market growth as more patients seek convenient user-friendly MADs for managing sleep apnea.
• Key Market Trends: Key market trends include the increased awareness of sleep apnea and the rising preference for non-invasive treatments. Advancements in device technology, like 3D printing and customization are enhancing comfort and efficacy driving adoption. Telemedicine integration is also expanding access to these devices as patients nowadays are increasingly seeking home-based solutions. Favorable regulatory policies and insurance reimbursement are further encouraging the use of MADs. In addition to this, the market is witnessing a gradual shift toward eco-friendly and hypoallergenic materials to meet the consumer demand for health-conscious and sustainable products.
• Geographical Trends: The market shows significant growth in North America mainly due to its high awareness of sleep apnea, advanced healthcare infrastructure and favorable reimbursement policies. Europe follows by closely, driven by the rising prevalence of sleep disorders and supportive regulatory frameworks. The Asia-Pacific region is also experiencing significant growth, fueled by increasing healthcare awareness, a rising patient population, and the widespread adoption of non-invasive treatments. Emerging markets in Latin America and the Middle East are also gaining significant traction as awareness of sleep apnea spreads and healthcare infrastructure improves in these regions, thus supporting the future demand for MADs.
• Competitive Landscape: Some of the major market players in the mandibular advancement devices industry include Advanced Brain Monitoring Inc., Apnea Sciences Corporation, DynaFlex, Erkodent Erich Kopp GmbH, NDX Keller Dental Lab, OSCIMED SA, ResMed, Scheu-Dental GmbH (Armira Partners GmbH & Co KG), SomnoMed, The Aurum Group and Tomed GmbH, among many others.
• Challenges and Opportunities: The market faces various challenges such as high device costs, limited patient awareness in some regions and growing competition from alternative treatments like CPAP therapy. However, there are significant opportunities, including technological advancements in customization and comfort, rising awareness of sleep apnea and growing demand for non-invasive home-based treatments. Expanding healthcare infrastructure in emerging markets along with supportive regulatory frameworks and insurance coverage, is also opening up new avenues for market expansion.
   

Mandibular Advancement Devices Market Trends:

Rising Demand for Sleep Apnea Treatment

The growing awareness of sleep disorders mainly obstructive sleep apnea (OSA) is driving the demand for mandibular advancement devices (MADs). OSA is a condition where breathing repeatedly stops during sleep due to throat muscle relaxation leading to health risks such as heart disease and high blood pressure. In a recent study, it was found that the prevalence of moderate-severe obstructive sleep apnea (OSA) in the Indian population is 32.5%, which is a significantly higher rate as compared to previous studies. While CPAP therapy is widely recommended, many patients find it cumbersome due to discomfort, noise, and the need for a continuous air supply. MADs, which reposition the lower jaw to keep the airway open, offer a more comfortable, non-invasive alternative, encouraging patient adherence and improving treatment outcomes for OSA. The mandibular advancement devices market report anticipates continuous growth as the prevalence of obstructive sleep apnea (OSA) rises worldwide.

Rising Regulatory Support

Favorable regulatory frameworks and insurance reimbursements are playing a crucial role in boosting the adoption of mandibular advancement devices (MADs) for sleep apnea treatment. Regulatory bodies, such as the FDA and equivalent global agencies, have approved MADs as an effective alternative to CPAP therapy, which has led to wider acceptance in clinical practices. Additionally, the inclusion of MADs under insurance coverage reduces the financial burden on patients, making these devices more accessible. With reimbursement policies covering a significant portion of treatment costs, more patients are seeking MADs, contributing positively to the mandibular advancement devices market growth in the sleep apnea treatment sector. For instance, in December 2023, the FDA approved the first oral devices to treat severe obstructive sleep apnea (OSA). Manufactured by Vivos Therapeutics, Inc., these devices, called Complete Airway Repositioning and Expansion (CARE) appliances, offer an alternative to CPAP therapy and surgery. Studies show that about 80% of patients experienced improvement in sleep apnea symptoms.

Integration of Telemedicine

Telemedicine is playing an increasingly pivotal role in sleep apnea diagnosis and treatment, making it easier for patients to receive care from home. With advancements in remote monitoring and virtual consultations, patients can now be diagnosed and managed without frequent in-person visits. This has increased the demand for mandibular advancement devices (MADs) that are user-friendly and effective in-home settings. The integration of telemedicine allows for more personalized adjustments and continuous follow-up, ensuring better compliance and treatment outcomes, while offering patients the convenience of addressing their sleep apnea without the challenges of traditional clinic visits. For instance, in January 2023, BlueSleep launched a custom telemedicine platform as part of its commitment to improving the diagnosis and treatment of sleep apnea. The platform, integrated with BlueSleep's patient portal, allows healthcare providers to access patient profiles, sleep questionnaires, and home sleep tests from a virtual waiting room. Providers can engage with patients via chat, screen sharing, and multi-party calls while also monitoring visit and wait times.

Mandibular Advancement Devices Market Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the global, regional, and country levels for 2024-2032. Our report has categorized the market based on product, application, material type and distribution channel.

Breakup by Product:

• Bite MAD
• Custom MAD
• Semi-Custom MAD
   

The report has provided a detailed breakup and analysis of the market based on the product. This includes bite MAD, custom MAD and semi-custom MAD.

Bite MADs are pre-fabricated oral devices that help treat sleep apnea by repositioning the lower jaw slightly forward during sleep. They are often adjustable, allowing users to modify the fit based on comfort and effectiveness. These devices are relatively affordable and accessible, making them a popular choice for individuals seeking non-invasive treatments for mild to moderate obstructive sleep apnea (OSA) or snoring. However, they may not provide the same level of customization and comfort as more tailored options like custom-made devices.

Custom MADs are specifically molded to fit an individual’s dental structure, offering a more precise and comfortable fit compared to standard or semi-custom devices. These devices are often made by dental professionals after detailed impressions of the user's teeth and jaw are taken. Custom MADs are known for their effectiveness in treating moderate to severe obstructive sleep apnea (OSA) and reducing snoring. Although they tend to be more expensive than other types, their high level of customization often results in better patient compliance and long-term effectiveness.

Semi-custom MADs offer a middle ground between bite MADs and fully custom devices. They are adjustable to a certain degree and can be adapted to fit the user’s dental structure more closely than a standard bite MAD, but without the same level of personalization as custom devices. Semi-custom MADs are typically more affordable than custom-made options while still offering increased comfort and efficacy. They are a suitable option for those seeking a balance between cost and a more tailored fit for managing sleep apnea or snoring.

Breakup by Application:

• Snoring
• Obstructive Sleep Apnea
• Temporomandibular Joint Syndrome
• Others
   

A detailed breakup and analysis of the market based on the application have also been provided in the report. This includes snoring, obstructive sleep apnea, temporomandibular joint syndrome and others.

Mandibular Advancement Devices (MADs) are commonly used to manage snoring by repositioning the lower jaw forward, which helps open the airway during sleep. This adjustment reduces the vibration of soft tissues in the throat, which is the primary cause of snoring. These devices are effective for individuals with mild to moderate snoring issues, offering a non-invasive solution. By improving airflow and reducing airway obstructions, MADs can significantly lessen or eliminate snoring, improving sleep quality for both the user and their partner.

Mandibular Advancement Devices (MADs) are a recognized treatment for Obstructive Sleep Apnea (OSA), particularly in mild to moderate cases. OSA occurs when the airway becomes blocked during sleep, leading to breathing interruptions. MADs reposition the lower jaw to keep the airway open, preventing blockages and improving airflow. These devices offer a less invasive alternative to Continuous Positive Airway Pressure (CPAP) machines and can enhance sleep quality and reduce daytime fatigue associated with OSA. They are often used as a first-line treatment for patients seeking a non-surgical solution.

For individuals with Temporomandibular Joint Syndrome (TMJ), some specialized Mandibular Advancement Devices (MADs) are designed to alleviate the strain on the jaw joints while managing sleep-related issues. These devices help reposition the lower jaw in a way that reduces tension on the TMJ during sleep, potentially relieving pain and discomfort. However, care must be taken as improper use of MADs can exacerbate TMJ symptoms. A properly fitted device can offer relief from both TMJ and sleep-related disorders, making them a useful tool for dual management.

Breakup by Material Type:

• Metal
• Plastic
   

Plastic represents the leading market segment 

The report has provided a detailed breakup and analysis of the market based on the material type. This includes metal and plastic. According to the report, plastic represented the largest segment.

According to mandibular advancement devices market research report, plastic holds the largest segment in the market due to its lightweight, cost-effectiveness, and ease of customization. Plastic MADs offer flexibility in design, allowing for comfortable, user-specific molds. They are also durable and less likely to cause discomfort compared to metal alternatives. The affordability of plastic makes these devices more accessible to a broader range of patients. Additionally, plastic MADs are easy to maintain, making them a popular choice for those seeking long-term management of sleep apnea and snoring. This dominance is expected to continue as demand rises.

Breakup by Distribution Channel:

• Hospitals Pharmacies
• Retail Pharmacies
• Online Stores
   

A detailed breakup and analysis of the market based on the distribution channel have also been provided in the report. This includes hospitals pharmacies, retail pharmacies, and online stores.

Hospital pharmacies serve as a key distribution channel for Mandibular Advancement Devices (MADs), particularly for patients diagnosed with obstructive sleep apnea (OSA) or other sleep-related disorders in clinical settings. These pharmacies often collaborate with healthcare providers to ensure that patients receive personalized guidance on MADs based on their medical needs. Hospital pharmacies are trusted for their access to specialized medical advice, ensuring that patients get the right fit and type of device, making them a reliable source for medical-grade MADs.

Retail pharmacies provide a more accessible option for patients seeking Mandibular Advancement Devices (MADs), especially for conditions like snoring or mild sleep apnea. These pharmacies typically offer a variety of over-the-counter MADs that don't require a prescription, catering to individuals looking for a quick and convenient solution. Retail pharmacies also serve as a middle ground, offering devices that may not be as customizable as those from hospital pharmacies, but are more affordable and easier to purchase without extensive medical consultation.

Online stores are becoming increasingly popular for purchasing Mandibular Advancement Devices (MADs), offering convenience, variety, and often lower prices. Patients can easily compare different types of devices, read reviews, and access detailed product descriptions from the comfort of their home. Online platforms also offer direct-to-consumer custom MADs, where users can take dental impressions at home and order personalized devices. This channel is growing in popularity due to its accessibility and the ability to reach a broader audience beyond traditional brick-and-mortar stores.

Breakup by Region:

• North America
  • United States
  • Canada
• Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
• Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
• Latin America
  • Brazil
  • Mexico
  • Others
• Middle East and Africa
   

North America leads the market, accounting for the largest mandibular advancement devices market share

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America represents the largest regional market for mandibular advancement devices.

North America dominates the Mandibular Advancement Devices (MAD) market due to its high prevalence of obstructive sleep apnea (OSA) and snoring disorders. The region’s advanced healthcare infrastructure, greater awareness of sleep disorders, and growing demand for non-invasive treatments are driving the mandibular advancement devices demand significantly. The presence of key market players and supportive reimbursement policies also play a role in driving market growth. Additionally, the widespread adoption of technologically advanced devices and greater investment in sleep disorder research further enhance North America's market share in the MAD sector. For instance, in May 2024, Glidewell introduced the Silent Nite® 3D Sleep Appliance, a 3D-printed mandibular advancement device designed to help with snoring and mild to moderate obstructive sleep apnea. This innovative device, made of durable light-cured resin, gently shifts the mandible forward to prevent airway collapse during sleep. With approximately 39 million adults in the United States suffering from sleep apnea, this new solution offers promising relief. These advancements, combined with the rising prevalence of sleep disorders and the rising demand for non-invasive treatment options, are creating positive mandibular advancement devices market outlook.

Competitive Landscape:

• The market research report has also provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the major market players in the mandibular advancement devices industry include Advanced Brain Monitoring Inc., Apnea Sciences Corporation, DynaFlex, Erkodent Erich Kopp GmbH, NDX Keller Dental Lab, OSCIMED SA, ResMed, Scheu-Dental GmbH (Armira Partners GmbH & Co KG), SomnoMed, The Aurum Group and Tomed GmbH.
  
  (Please note that this is only a partial list of the key players, and the complete list is provided in the report.)
   
• The mandibular advancement devices (MAD) market is highly competitive, with numerous players offering innovative solutions to treat sleep apnea and snoring. Companies are focusing on product differentiation through customization, comfort, and technological advancements, such as 3D-printed devices and improved materials. The increasing demand for non-invasive treatments has driven manufacturers to invest in research and development (R&D) significantly, leading to more efficient and comfortable devices. The market competition is also influenced by strategic partnerships, expanding distribution channels, and favorable reimbursement policies, all of which contribute to the growing adoption of MADs globally. According to the mandibular advancement devices market forecast, the market is expected to experience steady growth due to rising awareness and technological innovations.

Mandibular Advancement Devices Market News:

• In January 2024, Elite Swiss Made Mandibular Advancement Device by SnoreLessNow received FDA clearance, offering an over-the-counter (OTC) solution to snoring. The Anti-Snore Mouth Guard+ positions the jaw forward to enhance airflow and reduce airway obstruction, using high-quality Swiss biomedical polymers.
• In April 2024, Smartee Dental Technology introduced the S8 aligners, a groundbreaking solution for severe Class II malocclusion. These invisible aligners achieve mandibular advancement and tooth alignment simultaneously, offering an efficient and minimally invasive treatment. The custom manufactured S8 aligners correct malocclusion by modifying growth patterns of orofacial bone structures. This innovative technology has the potential to revolutionize orthodontic treatment, especially for severe malocclusion involving skeletal components.

Mandibular Advancement Devices Market Report Scope:

Key Questions Answered in This Report:

• How has the global mandibular advancement devices market performed so far, and how will it perform in the coming years?
• What are the drivers, restraints, and opportunities in the global mandibular advancement devices market?
• What is the impact of each driver, restraint, and opportunity on the global mandibular advancement devices market?
• What are the key regional markets?
• Which countries represent the most attractive mandibular advancement devices market?
• What is the breakup of the market based on the product?
• Which is the most attractive product in the mandibular advancement devices market?
• What is the breakup of the market based on the application?
• Which is the most attractive application in the mandibular advancement devices market?
• What is the breakup of the market based on the material type?
• Which is the most attractive material type in the mandibular advancement devices market?
• What is the breakup of the market based on the distribution channel?
• Which is the most attractive distribution channel in the mandibular advancement devices market?
• What is the competitive structure of the market?
• Who are the key players/companies in the global mandibular advancement devices market?

Key Benefits for Stakeholders:

• IMARC’s industry report offers a comprehensive quantitative analysis of various market segments, historical and current market trends, market forecasts, and dynamics of the mandibular advancement devices market from 2018-2032.
• The research report provides the latest information on the market drivers, challenges, and opportunities in the global mandibular advancement devices market.
• The study maps the leading, as well as the fastest-growing, regional markets. It further enables stakeholders to identify the key country-level markets within each region.
• Porter's five forces analysis assists stakeholders in assessing the impact of new entrants, competitive rivalry, supplier power, buyer power, and the threat of substitution. It helps stakeholders to analyze the level of competition within the mandibular advancement devices industry and its attractiveness.
• The competitive landscape allows stakeholders to understand their competitive environment and provides insight into the current positions of key players in the market.